This artcile has been updated following a correction issued by Diagnostic Hybrids on Sep. 2.

NEW YORK (GenomeWeb News) – Diagnostic Hybrids on Wednesday issued a correction to an earlier statement and said that the US Food and Drug Administration has not cleared any additional claims or new intended uses for its respiratory virus test kit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.